Oncolytic vesicular stomatitis virus quantitatively and qualitatively improves primary CD8(+) T-cell responses to anticancer vaccines

The ability of heterologous prime-boost vaccination to elicit robust CD8(+) T cell responses has been well documented. In contrast, relatively little is known about how this immunotherapeutic strategy impacts the functional qualities of expanded T cells in the course of effector and memory responses...

Descripción completa

Detalles Bibliográficos
Autores principales: Bridle, Byram W, Clouthier, Derek, Zhang, Liang, Pol, Jonathan, Chen, Lan, Lichty, Brian D, Bramson, Jonathan L, Wan, Yonghong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3782525/
https://www.ncbi.nlm.nih.gov/pubmed/24083086
http://dx.doi.org/10.4161/onci.26013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3782525/
https://www.ncbi.nlm.nih.gov/pubmed/24083086
http://dx.doi.org/10.4161/onci.26013

Ejemplares similares